1 not yet recruiting, 1 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Unknown 1 |
Follow CIN3: new trials by email Literature Review of CIN3 trials Research Report on CIN3
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya 5% 5-fluorouracil Topical Cream, Placebo Cream - HIV Infections, HPV Infection | Phase 2 | Not yet recruiting | UNC Lineberger Comprehensive Cancer Center | 140 | 2026-09-01 | 2026-08-27 |
| Vvax001 Cancer Vaccine in Premalignant Cervical Lesions - Phase II Vvax001 therapeutic cancer vaccine - CIN3, Cervical Intraepithelial Neoplasia | Phase 2 | Unknown | University Medical Center Groningen | 18 | 2021-03-23 | 2023-08-29 |
Uterine Cervical Dysplasia (2) · HIV Infections (1) · Papillomavirus Infections (1) · Uterine Cervical Neoplasms (1)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Neoplasms (2) · Precancerous Conditions (2) · Urogenital Diseases (2) · Uterine Cervical Diseases (2) · Uterine Diseases (2) · Blood-Borne Infections (1) · Communicable Diseases (1) · DNA Virus Infections (1) · Disease Attributes (1) · Genital Neoplasms, Female (1) · Immune System Diseases (1)
UNC Lineberger Comprehensive Cancer Center (1) · University Medical Center Groningen (1)
Kenya (1) · Netherlands (1)
R37CA306827 (1)